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Introduction
A properly regulated inflammatory response protects the host from infection and aids in restoring the structure and function of damaged tissues following injury. However, severe or persistent inflammation can lead to many serious acute and chronic diseases, such as systemic inflammatory response syndromes (SIRS), acute lung injury, inflammatory bowel disease (IBD), atherosclerosis, and many more.
Irrespective of the affected organ, dysregulated inflammation can lead to organ damage, dysfunction, and failure. In a typical controlled inflammatory response, an inductive phase is followed by a sustained response, which declines and ends when the processes triggered by the initial responses are halted. Thus, correct coordination and timely resolution of the inflammatory response are critical in maintaining the balance between health and disease. However, although mechanisms instigating and perpetuating inflammatory responses have been studied extensively, less is known about the mechanisms governing the resolution of inflammation.
Heparan sulfate (HS) and its pharmaceutical functional analogue, heparin, bind to and regulate many inflammatory factors in vitro 1, 2 . HS and heparin are linear polysaccharides comprised of repeating disaccharide units of hexuronic acid, either glucuronic or iduronic acid, alternating with unsubstituted or N-substituted glucosamine on which the substituents are either acetate or sulfate 1, 2 . Heparin possesses anti-inflammatory activities in several human inflammatory diseases, such as asthma 3 and IBD 4 . Clinical studies also show that low dose heparin increases the odds of survival in patients with sepsis 5 , suggesting that heparin inhibits the deleterious consequences of dysregulated inflammation. However, heparin apparently does not attenuate inflammation through its anticoagulant activities 3, 6 . Native heparin is found in intracellular vesicles of mast cells, whereas HS is ubiquitously expressed on the surface of cells and in the extracellular matrix. Because HS contains all of the structural motifs present in heparin and all HS in vivo are found covalently conjugated to specific core proteins as HS proteoglycans (HSPGs), the physiological counterpart of pharmaceutical heparin is likely to be HS.
The syndecan family of type I transmembrane HSPGs, comprised of four members in mammals (syndecan-1 through -4), is the major source of cell surface HS 1, 7 . Although all syndecans contain the For personal use only. on September 13, 2017 . by guest www.bloodjournal.org From ligand-binding HS chains, they are expressed on different cell types in different locations and, hence, likely perform specific functions in vivo 1, 8 . For example, syndecan-1 is predominantly expressed by epithelial cells, though it is also expressed by other cell types to a lesser degree (e.g., endothelial cells).
Syndecans function as coreceptors by capturing HS-binding ligands and increasing ligand concentration
in the pericellular vicinity of their respective signaling receptors 1, 7 .
In response to injury or infection, the ectodomain of syndecan-1 is proteolytically shed from the cell surface by metalloproteinases, enabling syndecan-1 to also function as soluble HSPGs 1, 7 . Several inflammatory mediators enhance syndecan-1 shedding in vitro [9] [10] [11] [12] [13] and certain pathological conditions induce shedding in vivo [14] [15] [16] [17] [18] [19] [20] . In humans, syndecan-1 ectodomains are detected in skin wound fluids, tracheal aspirates of intubated pre-term infants, and blood of patients with acute graft-versus-host disease or myeloma 13, 15, 19, 21 . In mice, elevated levels of syndecan-1 ectodomains are found in lungs of mice challenged with Pseudomonas aeruginosa 17 , Staphylococcus aureus β-toxin 22 , bleomycin 16 or allergens 18 , and in blood of mice challenged with Gram-positive superantigens 20 . Results from these studies suggest that syndecan-1 shedding protects the host from dysregulated inflammation. For example, in the mouse model of allergic lung inflammation, intranasal inoculation of allergens stimulates airway syndecan-1 shedding and syndecan-1 ectodomain attenuates lung inflammation by inhibiting Th2 cell homing to the lung 18 . Consistent with this mechanism, allergen-instilled syndecan-1 null (Sdc1-/-) mice show exaggerated lung inflammation relative to wild type (WT) mice. These observations suggest that syndecan-1 shedding is an important host response that assures the adequate and correct functioning of inflammatory processes, but the underlying mechanisms have remained elusive.
In the present study, we show that syndecan-1 facilitates the resolution of neutrophilic inflammation in a mouse model of endotoxemia. Syndecan-1 does not affect the systemic or local expression of inflammatory factors, but it specifically facilitates the removal of the CXC chemokines, KC (CXCL1, an IL-8 ortholog) and MIP-2 (CXCL2), in multiple organs. Further, we show that syndecan-1 shedding is induced at later times post-LPS infusion, and inhibition of shedding interferes with the removal of KC and MIP-2, and resolution of neutrophilic inflammation in various organs. In contrast, HS infusion
For personal use only. on September 13, 2017 . by guest www.bloodjournal.org From improves survival by inhibiting the sequestration of KC and MIP-2, tissue neutrophilia, and multi-organ injury. These data uncover a previously unknown mechanism that facilitates the resolution of neutrophilic inflammation.
Materials and Methods

Reagents
E. coli O111:B4 LPS was purchased from Calbiochem (La Jolla, CA). Rat anti-mouse GR-1 (clone RBC6-8C5) and rat anti-mouse CD14 (159010) monoclonal antibodies were from R&D Systems (Minneapolis, MN), rat anti-mouse syndecan-1 (281-2) monoclonal antibodies were from BD Pharmingen (San Diego, CA), rat anti-mouse syndecan-4 (Ky8.2) monoclonal antibodies were from Dr. Paul Kincade (Oklahoma Medical Research Foundation), rabbit anti-cleaved caspase 3 monoclonal antibodies were from Cell Signaling (Danvers, MA), and Alexa 594 donkey anti-rat and Alexa 488 goat anti-rabbit antibodies were from Invitrogen (Carlsbad, CA). Bovine kidney HS was from MP Biomedicals (Irvine, CA), red blood cell lysis buffer were from Sigma (St. Louis, MO), and GM6001 was from Millipore (Billerica, MA).
Mouse model of endotoxemia
Unchallenged Sdc1-/-mice are healthy with normal growth, reproduction, tissue morphology, CBC counts, and serum chemistry parameters 17, 23 . Sdc1-/-mice on the C57BL/6J background and littermate WT mice were used at an age of 6-9 wk. Mice were injected intraperitoneally with LPS, GM6001, or HS in 100 μl of sterile saline at the indicated doses. All animal experiments were approved by the Institutional Animal Care and Use Committee of Children's Hospital, Harvard Medical School, and complied with federal guidelines for research with experimental animals.
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Protein assays
Serum was prepared from blood collected by cardiac puncture. Tissues were weighed and homogenized.
Cytokines and chemokines in serum and tissue homogenates were measured by ELISA (R&D Systems).
Plasma, prepared from citrate-anticoagulated blood, was used to measure circulating levels of the thrombin-antithrombin III (TAT) complex by ELISA (Dade Behring, Deerfield, IL) and activated partial thromboplastin time (APTT) using a kit from Trinity Biotech (Berkeley Heights, NJ). Organ injury and dysfunction markers were measured using an automated Cobas Integra 400 Plus serum chemistry analyzer. CBC analysis was performed using the Bayer Advia 120 hematology analyzer.
RT-PCR
Total RNA (200 ng) was reverse-transcribed and amplified using the Superscript one-step RT-PCR kit 
Splenocytes
Splenocytes were prepared by straining isolated spleens through 70 μm screens (Falcon, Franklin Lakes, NJ) and lysing erythrocytes in red blood cell lysis buffer. Splenocytes were suspended in RPMI with 10% FCS and 2x10 7 cells were cultured for 2 h in 24 well plates. Non-adherent cells were washed away and adherent splenocytes (~1x10 6 cells/well) were incubated with 100 ng/ml LPS for 24 h at 37°C.
Histology
WT and Sdc1-/-tissues were isolated at various times post-LPS, fixed in 4% paraformaldehyde/PBS for 2 d at 4°C, embedded in paraffin, and sectioned. Tissue sections (5 μm) were stained with hematoxylineosin or immunostained with anti-mouse GR1, 281-2 anti-mouse syndecan-1 ectodomain, anti-mouse CD14, or anti-cleaved caspase-3 antibodies and Alexa 594 anti-rat or Alexa 488 anti-rabbit antibodies.
Syndecan shedding assay
Serum levels of syndecan-1 and -4 ectodomains were assessed by a dot immunoblot assay as described previously 11, 12 . Briefly, 10-50 μl of serum collected at various times post-LPS were diluted in TBS and dot blotted onto a cationic nylon membrane (Immobilon Ny+, Millipore) and the concentration of shed ectodomains was quantified using 281-2 anti-syndecan-1 or Ky8.2 anti-syndecan-4 ectodomain antibodies.
Statistical analyses
All data are expressed as mean±SE. Differences between experimental groups and respective controls were examined by Student's t-test, and differences in survival values were compared by Fisher's exact test. P values of <0.05 were considered statistically significant.
Results
Sdc1-/-mice are susceptible to LPS-induced multi-organ injury and lethal endotoxemia
We first tracked the survival of WT and Sdc1-/-mice injected intraperitoneally with various doses of LPS. Only 10 or 30% of WT mice died, and only within the first 2 d, during the course of a 7 d experiment in response to 4.5 or 6.75 mg/kg LPS, respectively (Fig. 1A) . However, all Sdc1-/-mice died by 5 d post-LPS at both doses (Fig. 1A) . Next, we assessed the extent of multi-organ injury and dysfunction by measuring serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), and lactic dehydrogenase (LDH). We also measured the lung wet/dry ratio as an indicator of pulmonary edema and assessed lung injury by histology. We used 4.5 mg/kg LPS in this and subsequent experiments, a lethal dose for Sdc1-/-mice but a sub-lethal dose for WT mice. Starting at 24 h post-LPS, Sdc1-/-mice exhibited elevated levels of organ dysfunction markers compared to WT mice and, by 48 h post-LPS, serum levels of ALT (4-fold), AST (3-fold), BUN (6-fold), and LDH (2-fold) were significantly increased in Sdc1-/-mice relative to WT mice ( 
Removal of tissue-associated KC and MIP-2 is inhibited in endotoxemic Sdc1-/-mice
To determine the underlying cause of the exaggerated host response to LPS in Sdc1-/-mice, we tested if syndecan-1 binds to and neutralizes LPS. Radiolabeled syndecan-1 did not bind to LPS by ligand blotting and LPS did not bind to heparin by affinity chromatography (not shown). We next examined the systemic inflammatory response in endotoxemic Sdc1-/-mice. Increased and decreased systemic levels of pro-and anti-inflammatory factors, respectively, are thought to lead to the development of multi-organ dysfunction and failure in SIRS 24 . However, no significant differences in serum levels of the proinflammatory factors, TNFα, IL-1β, IL-6, KC or MIP-2, or the anti-inflammatory cytokine IL-10 were found between genotypes ( Fig. 2A) . Similarly, serum levels of IFN-γ, FasL, TGFβ1, G-CSF, and IL-1RA
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These data indicate that syndecan-1 deficiency does not affect the systemic inflammatory response to LPS challenge.
We also examined if aberrant hemostatic responses were associated with the enhanced host responses in endotoxemic Sdc1-/-mice. LPS activates systemic coagulation and disseminated intravascular coagulation 25 , and some consider cell surface HSPGs as endogenous heparin-like molecules that maintain an anticoagulant state in the vasculature 26, 27 . Both WT and Sdc1-/-mice showed similar extent of thrombocytopenia at 48 h post-LPS (Fig. 2B) . Further, plasma levels of the thrombinantithrombin III (TAT) complex ( Fig. 2C ) and the activated partial thromboplastin time (APTT) (not shown) were similar between endotoxemic WT and Sdc1-/-mice. These data suggest that syndecan-1
does not affect the hemostatic responses in murine endotoxemia.
We next examined if the local inflammatory response to LPS is dysregulated in Sdc1-/-mice. Lungs and livers from WT and Sdc1-/-mice were harvested at 7 and 30 h post-LPS, and TNFα, IL-6, KC, and MIP-2 levels in tissue homogenates were measured by ELISA (Fig. 3A) . Tissue levels of TNFα and IL-6
were similar between endotoxemic WT and Sdc1-/-mice. Similarly, tissue levels of KC and MIP-2 were markedly elevated at 7 h post-LPS in both genotypes. However, although both KC and MIP-2 returned to baseline by 30 h post-LPS in WT mice, they remained significantly elevated in endotoxemic Sdc1-/-mice. At 30 h post-LPS, lung and liver levels of KC were 6-and 8-fold higher, and those of MIP-2 were 11-and 19-fold higher in Sdc1-/-mice than those in WT mice (Fig. 3A) .
To assess if sustained high levels of tissue KC and MIP-2 were due to continued production, we measured mRNA levels of these chemokines in LPS-injected WT and Sdc1-/-tissues. Lung KC and MIP-2 mRNA were similarly increased at 15 h post-LPS and dropped to near basal levels by 48 h post-LPS in both genotypes (Fig. 3B) . Similar results were obtained using WT and Sdc1-/-liver (not shown). We examined if Sdc1-/-cells produce higher amounts of KC and MIP-2 in response to LPS. WT and Sdc1-/-splenocytes were stimulated with LPS, and TNFα, IL-6, KC, and MIP-2 in the conditioned medium were measured. Both WT and Sdc1-/-splenocytes produced similar levels of cytokines and chemokines in response to LPS (Fig. 3C) . Together, these data indicate that the sustained high levels of KC and MIP-2 in Sdc1-/-tissues are not due to increased production. Instead, these results indicate that syndecan-1 facilitates the clearance of KC and MIP-2 in tissues during the resolution of inflammation, and the absence of syndecan-1 impedes this process in endotoxemic Sdc1-/-mice.
Resolution of neutrophilic inflammation is impeded in endotoxemic Sdc1-/-mice
A key event during an inflammatory response is the recruitment of leukocytes to the site of injury, immune response, or infection. KC and MIP-2 are the major CXC chemokines that provide chemotactic signals for neutrophil infiltration 28, 29 . Neutrophils are typically the first type of leukocytes recruited to sites of infection and injury. Although an essential arm of innate immunity, several studies have implicated neutrophils in contributing greatly to tissue damage associated with dysregulated inflammation 30, 31 . Thus, we assessed if increased tissue levels of KC and MIP-2 led to exaggerated neutrophil accumulation in endotoxemic Sdc1-/-mice. Lung, liver, and kidney harvested from WT and Sdc1-/-mice at 15 and 48 h post-LPS were immunostained for GR1, a mouse neutrophil-specific antigen. At 15 h post-LPS, abundant GR1-positive neutrophils were seen within the lung alveolar walls, in the liver interstitium and microcapillaries, and in the kidney interstitium and glomeruli in both WT and Sdc1-/-mice (Fig. 4A ).
These findings indicate that syndecan-1 deficiency does not affect the initial accumulation of neutrophils and are consistent with similar tissue levels of KC and MIP-2 at earlier times post-LPS in WT and Sdc1-/-mice ( Fig. 3A) . At 48 h post-LPS, sparse anti-GR1 staining was seen in WT organs, indicating that the signals for neutrophil influx have been removed, neutrophil infiltration has been halted, and infiltrated neutrophils have been cleared (Fig. 4A) . However, large number of neutrophils remained in Sdc1-/-organs at 48 h post-LPS ( 
Syndecan-1 ectodomain shedding is induced in endotoxemic WT mice
Based on these data, we propose that syndecan-1 moderates neutrophilic inflammation by facilitating the removal of tissue-associated KC and MIP-2. To begin defining how syndecan-1 functions, we examined the expression of syndecan-1 in endotoxemic WT mice. Tissue sections of WT lung and liver harvested before and after LPS infusion were immunostained with the 281-2 anti-syndecan-1 ectodomain antibody (Fig. 5A) . Untreated lungs showed strong cell surface syndecan-1 expression in mostly cuboidal type II epithelial cells of alveoli. Untreated livers showed intense 281-2 immunoreactivity on the sinusoidal side of hepatocytes, indicating that syndecan-1 is abundantly expressed on the cell surface of hepatocytes and/or endothelial cells. In contrast, the signal for cell surface syndecan-1 in the lung and liver was significantly reduced at 24 h post-LPS (Fig. 5A) . Because steady-state syndecan-1 mRNA levels were similar in the lung and liver at 0, 6, and 24 h post-LPS (not shown), the reduced cell surface expression suggested that syndecan-1 ectodomains were shed from various organs in endotoxemic WT mice. Indeed, whereas serum levels of syndecan-1 ectodomains were low in unchallenged WT mice, they increased progressively up to 24 h post-LPS and high levels were sustained at 48 h post-LPS (Fig. 5B) .
Levels of syndecan-4 ectodomains in serum were also increased at 8 h post-LPS, but unlike syndecan-1, syndecan-4 quickly dropped to basal levels (Fig. 5B) . Further, serum syndecan-1 ectodomains were not detected when probed with antibodies directed against the syndecan-1 cytoplasmic domain 11 , verifying that syndecan-1 ectodomains were shed and not released from damaged cells (not shown). Interestingly, we found that levels of syndecan-4 ectodomains are increased in LPS-infused Sdc1-/-mice compared to LPS-infused WT mice (Fig. 5B) . These data indicate that although syndecan-4 shedding is increased in Sdc1-/-mice, it does not functionally compensate for the loss of syndecan-1 in endotoxemic Sdc1-/-mice, suggesting that syndecan-1 functions specifically in the resolution of neutrophilic inflammation. The extent of syndecan-1 shedding was assessed by immunostaining tissue sections for cell surface syndecan-1 and by measuring serum levels of syndecan-1 ectodomains at 40 h post-LPS. Cell surface syndecan-1 levels were higher in the lung and liver of WT mice infused with GM6001 compared to those that received LPS only (Fig. 6A) . Further, administration of GM6001 significantly reduced circulating levels of syndecan-1 ectodomains (Fig. 6B) , indicating that delayed administration of GM6001 inhibited syndecan-1 shedding when neutrophilic inflammation was actively resolved. Importantly, infusion of GM6001 inhibited the removal of KC and MIP-2, and significantly increased chemokine levels in both
Syndecan
For personal use only. on September 13, 2017. by guest www.bloodjournal.org From the lung and liver (Fig. 6C) . Consistent with these data, GR1-positive neutrophils were also markedly increased in endotoxemic mice that received GM6001 compared to those that were administered LPS only (Fig. 6D) . Moreover, whereas only 1/10 WT mice that received LPS died, 5/9 WT mice that received GM6001 died by 3 d post-LPS. Injection of GM6001 without LPS did not increase tissue chemokine mRNA or protein levels, neutrophil accumulation, or mortality (not shown). These results suggest that inhibition of syndecan-1 shedding inhibits the removal of tissue-associated KC and MIP-2 and resolution of neutrophilic inflammation in multiple organs, and exacerbates disease.
To further define how syndecan-1 resolves neutrophilic inflammation, we examined if administration of HS, the ligand-binding moiety of syndecan-1, will facilitate the removal of tissueassociated KC and MIP-2 and accumulated neutrophils. Sdc1-/-mice were injected with or without HS at 10 h post-LPS and tissue levels of KC and MIP-2 were measured at 30 h post-LPS. Delayed HS infusion significantly reduced KC and MIP-2 levels in both the lung and liver in endotoxemic Sdc1-/-mice (Fig.   7A ). Tissue levels of IL-6 and TNFα were not significantly affected (not shown). Consistent with these findings, GR1-positive neutrophils were also markedly reduced in Sdc1-/-mice injected with HS relative to mice injected with LPS only (Fig. 7B) . Further, all Sdc1-/-mice that were administered LPS only or LPS and syndecan-1 core protein or chondroitin sulfate died by 5 d post-LPS, whereas only 10% of mice that received HS died during the course of the experiment (n=10 in each group). Altogether, these data indicate that syndecan-1 shedding is a critical endogenous mechanism that facilitates the resolution of neutrophilic inflammation by removing tissue-associated KC and MIP-2 in an HS-dependent manner.
Discussion
In this study, we report that syndecan-1 attenuates inflammatory tissue injury in endotoxemia by facilitating the removal of KC and MIP-2 and the resolution of neutrophilic inflammation. Our results showed that in mice lacking syndecan-1, LPS infusion leads to sustained high levels of KC, MIP-2, and neutrophils in various organs, overwhelming multi-organ injury and dysfunction, and significantly We also conclude that syndecan-1 shedding facilitates the resolution of neutrophilic inflammation.
Whereas systemic inflammation was evident by 1 h post-LPS, elevated levels of syndecan-1 ectodomains
were not detected in serum until after 8 h post-LPS. Importantly, inhibition of shedding by GM6001 at later times post-LPS impeded the removal of KC and MIP-2 from various organs and resolution of neutrophilic inflammation in endotoxemic WT mice. GM6001 was administered at 24 h post-LPS because our results indicated that KC and MIP-2 in tissues are removed between 7 and 30 h post-LPS, and also because pre-treatment or earlier infusion of GM6001 inhibits the shedding of TNFα at earlier times and protects mice from lethal endotoxemia 36 . Thus, although metalloproteinase inhibitors of ectodomain shedding may be beneficial if given before the onset of disease or very early, our data indicate that these agents may be detrimental if given at later stages of disease progression. In contrast to delayed GM6001 administration, delayed HS infusion facilitated the removal of KC and MIP-2 and accumulated neutrophils in various organs, attenuated multi-organ injury and dysfunction, and protected mice from lethal endotoxemia. Taken together, these data define the unique manner in which syndecan-1
shedding facilitates the resolution of neutrophilic inflammation by removing sequestered KC and MIP-2 in an HS-dependent manner.
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The precise manner in which syndecan-1 shedding facilitates the removal of KC and MIP-2 is not known. This mechanism, however, does not involve an effect on gene expression of KC and MIP-2, suggesting that LPS signaling events through TLR4 are not affected. All chemokines, including KC and MIP-2, bind to cell surface HSPGs through basic amino acid motifs, and this tethering mechanism is essential in preventing dispersion of locally produced soluble chemokines and forming a chemokine gradient to direct leukocyte infiltration to specific sites of tissue injury in vivo 37, 38 . The specific HSPG(s)
that tethers KC and MIP-2 to the cell surface has not been identified, but our results showed that syndecan-1 is abundantly expressed in the liver. We also showed that high levels of syndecan Alternatively or concurrently, syndecan-1 shedding may also facilitate the resolution of inflammation by removing other sequestered CXC chemokines, such as macrophage migration inhibitory
factor (MIF) and LPS-induced CXC chemokine (LIX). Both LIX and MIF can bind to CXCR2 on
For personal use only. on September 13, 2017. by guest www.bloodjournal.org From neutrophils and have been implicated in neutrophil recruitment in LPS-induced acute lung injury and endotoxic shock [41] [42] [43] . Further, syndecan-1 shedding may facilitate neutrophilic inflammation by inhibiting selectin-mediated neutrophil adhesion and migration. Heparin inhibits neutrophil migration by interfering with P-and L-selectin-mediated cell adhesion 6 , and endothelial HS is a key ligand for L-selectinmediated neutrophil adhesion and migration in mouse models of acute peritonitis, contact dermatitis, and cutaneous air-pouch inflammation 44 . Thus, syndecan-1 shedding may also inhibit neutrophil infiltration by both rapidly removing the cell surface HS ligand for L-selectin and generating syndecan-1 ectodomains that can inhibit L-selectin-mediated adhesion. Future investigation of the potential functions of syndecan-1 shedding in selectin-mediated neutrophil adhesion and migration may reveal additional mechanisms of syndecan-1 in the resolution of neutrophilic inflammation.
The pro-resolving activity of exogenous HS suggests that HSPGs other than syndecan-1 can also protect the host from dysregulated neutrophilic inflammation. Indeed, Sdc4-/-mice are also susceptible to lethal endotoxemia compared to WT mice 45 . However, several lines of evidence indicate that syndecan-1 and -4 attenuate endotoxemia through distinct mechanisms. First, Sdc4-/-mice are thought to be prone to lethal endotoxemia because of elevated circulating levels of IL-1β. However, our studies showed that circulating levels of IL-1β are similar between endotoxemic Sdc1-/-and WT mice. Second, expression of syndecan-4 was induced in the liver upon LPS injection 45 , but syndecan-1 mRNA levels were unaffected and cell surface levels of syndecan-1 were significantly decreased by ectodomain shedding in all tissues examined. Third, the key phenotype we saw in endotoxemic Sdc1-/-mice -sustained high levels of CXC chemokines and neutrophils in multiple organs -was not seen in endotoxemic Sdc4-/-mice. Syndecan-1 has also been shown to play a critical modulatory role in several mouse models of inflammatory disorders, such as protein losing enteropathy 46 , allergic lung inflammation 18 , acute lung injury 16, 22 , and Gram-positive toxic shock 20 . These observations suggest that syndecan-1 shedding is an important process that protects the host from a wide variety of inflammatory disorders. However, how 49 , and MMP-7 is so far the only metalloproteinase that has been shown to shed syndecan-1 ectodomains both in vitro 34 and in vivo from the surface of an activated airway epithelium 16 . Altogether, these findings suggest that host cells attempt to protect itself from inflammatory tissue damage by sensing pro-inflammatory factors, such as TNFα, and mobilizing syndecan-1 shedding to facilitate the resolution of inflammation. The capacity of syndecan-1 shedding to facilitate the removal of CXC chemokines and de-activate neutrophil influx suggests that this is an important mechanism that modulates the progression and outcome of a broad spectrum of acute inflammatory disorders. In addition, because HS can regulate the activity of neutrophil granule proteins that can cause tissue damage 1, 50 , syndecan-1 may also modulate neutrophil-mediated tissue injury through these HS-dependent activities.
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